TY - GEN
T1 - Development of computer-aided diagnostic system for peritoneal dialysis
T2 - World Congress on Medical Physics and Biomedical Engineering: Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics
AU - Hamada, Hiroyuki
AU - Karino, T.
AU - Namoto, S.
AU - Yamashita, A. C.
AU - Ishizaki, M.
AU - Okamoto, M.
PY - 2009
Y1 - 2009
N2 - Peritoneal dialysis, which is well-known as the renal replacement therapy, has been widely prescribed for the end stage renal disease in the world. With peritoneal dialysis, most of the patients that have preservation of the residual renal function achieve a dialysis outcome and ultrafiltration volume that is necessary to maintain their homeostasis. However, the therapeutic efficiency of the peritoneal dialysis decreases gradually over the duration of peritoneal dialysis treatment. Therefore, a monitoring of both the peritoneal permeability and dialysis outcome is indispensable to explore an optimal prescription and implement a long-term peritoneal dialysis. We developed a novel computer-aided diagnostic system for the peritoneal dialysis (NAVI Light™) with employing both a kinetic mathematical model for peritoneal mass transfer and clinical test (NAVI test) which accumulates required clinical data. A set of unknown kinetic parameters on each patient were optimized by applying the clinical data to NAVI Light™. To evaluate a validity of the parameter optimization, we statis-tically analyzed a relationship between the ultrafiltration vol-ume and MTACu/c which was the ratio of MTAC for urea to that for creatinine. Since MTACu/c showed a positive correla-tion with the ultrafiltration volume, NAVI Light™ could ana-lyze the peritoneal permeability of various therapeutic stages. Using NAVI Light™, we estimated both the dialysis outcome and the ultrafiltation volume on the NAVI test, and analyzed a discrepancy between the estimated and the meas-ured data on the test. The estimated creatinine clearance, Kt/V for urea and ultrafiltration volume showed little discrepancy with measured those data. Moreover, those data on the ordinary prescription was also predicted by NAVI Light™, which were compared with observed data on the ordinary prescription. The predicted those data also agreed with observed data. Therefore, these findings demonstrated that NAVI Light™ is useful for analysis of the peritoneal permeability and exploration of better prescription.
AB - Peritoneal dialysis, which is well-known as the renal replacement therapy, has been widely prescribed for the end stage renal disease in the world. With peritoneal dialysis, most of the patients that have preservation of the residual renal function achieve a dialysis outcome and ultrafiltration volume that is necessary to maintain their homeostasis. However, the therapeutic efficiency of the peritoneal dialysis decreases gradually over the duration of peritoneal dialysis treatment. Therefore, a monitoring of both the peritoneal permeability and dialysis outcome is indispensable to explore an optimal prescription and implement a long-term peritoneal dialysis. We developed a novel computer-aided diagnostic system for the peritoneal dialysis (NAVI Light™) with employing both a kinetic mathematical model for peritoneal mass transfer and clinical test (NAVI test) which accumulates required clinical data. A set of unknown kinetic parameters on each patient were optimized by applying the clinical data to NAVI Light™. To evaluate a validity of the parameter optimization, we statis-tically analyzed a relationship between the ultrafiltration vol-ume and MTACu/c which was the ratio of MTAC for urea to that for creatinine. Since MTACu/c showed a positive correla-tion with the ultrafiltration volume, NAVI Light™ could ana-lyze the peritoneal permeability of various therapeutic stages. Using NAVI Light™, we estimated both the dialysis outcome and the ultrafiltation volume on the NAVI test, and analyzed a discrepancy between the estimated and the meas-ured data on the test. The estimated creatinine clearance, Kt/V for urea and ultrafiltration volume showed little discrepancy with measured those data. Moreover, those data on the ordinary prescription was also predicted by NAVI Light™, which were compared with observed data on the ordinary prescription. The predicted those data also agreed with observed data. Therefore, these findings demonstrated that NAVI Light™ is useful for analysis of the peritoneal permeability and exploration of better prescription.
UR - http://www.scopus.com/inward/record.url?scp=77950135708&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950135708&partnerID=8YFLogxK
U2 - 10.1007/978-3-642-03882-2_483
DO - 10.1007/978-3-642-03882-2_483
M3 - Conference contribution
AN - SCOPUS:77950135708
SN - 9783642038815
T3 - IFMBE Proceedings
SP - 1818
EP - 1821
BT - World Congress on Medical Physics and Biomedical Engineering
PB - Springer Verlag
Y2 - 7 September 2009 through 12 September 2009
ER -